Trevi Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018	2017
Market Capitalization	192	86	116	20	44	67	-	-
Market Cap Growth	-	-26.01%	472.04%	-54.55%	-33.49%	-	-	-
Enterprise Value	110	4	4	-2	14	10	-7	-17
PE Ratio	-2.94	-2.94	-3.97	-0.60	-1.36	-2.50	-	-
PB Ratio	2.32	1.04	1.08	1.18	1.63	1.23	-	-
P/FCF Ratio	-2.69	-2.69	-4.08	-0.70	-1.53	-2.89	-	-
P/OCF Ratio	-2.70	-2.70	-4.10	-0.70	-1.53	-2.90	-	-
EV/EBITDA Ratio	-0.14	-0.14	-0.15	0.06	-0.43	-0.38	0.35	1.75
EV/EBIT Ratio	-0.14	-0.14	-0.15	0.06	-0.43	-0.38	0.35	1.75
EV/FCF Ratio	-0.12	-0.12	-0.15	0.06	-0.48	-0.43	0.39	2.10
Debt / Equity Ratio	0.02	0.02	0.09	0.86	0.53	0.01	0.00	-0.06
Debt / EBITDA Ratio	-0.05	-0.05	-0.33	-0.45	-0.45	-0.01	0.00	-0.55
Debt / FCF Ratio	-0.04	-0.04	-0.32	-0.51	-0.50	-0.02	0.00	-0.66
Quick Ratio	14.25	14.25	8.99	2.89	8.10	11.02	2.69	3.09
Current Ratio	15.03	15.03	9.15	2.98	8.33	11.46	3.30	3.11
Interest Coverage	-73.42	-73.42	-24.10	-27.25	-70.88	-	-117.79	-2.86
Return on Equity (ROE)	-31.50%	-31.50%	-40.40%	-194.30%	-87.50%	-158.60%	26.40%	-
Return on Assets (ROA)	-28.90%	-28.90%	-32.10%	-89.30%	-64.20%	-49.00%	-156.20%	-
Return on Capital (ROIC)	-40.44%	-40.44%	-25.64%	-102.07%	-77.93%	-48.53%	16.82%	10.41%
Earnings Yield	-15.16%	-33.97%	-25.21%	-167.88%	-73.64%	-40.00%	-	-
FCF Yield	-16.61%	-37.22%	-24.50%	-143.18%	-65.27%	-34.54%	-	-
Buyback Yield / Dilution	-53.44%	-53.44%	-182.56%	-26.48%	-53.88%	-2581.79%	-4.02%	-
Total Shareholder Return	-53.44%	-53.44%	-182.56%	-26.48%	-53.88%	-2581.79%	-4.02%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).